Medicine & Life Sciences
Carcinoma, Intraductal, Noninfiltrating
100%
Clinical Trials, Phase I
59%
Vaccines
51%
Breast Neoplasms
34%
Immunization
17%
Immunity
16%
Tamoxifen
14%
Neoplasms
13%
Estrogen Antagonists
10%
Health
9%
Incidence
9%
Breast Cancer 3
9%
Extranodal Extension
9%
Uterine Neoplasms
8%
Costs and Cost Analysis
8%
Aromatase Inhibitors
8%
Drug Therapy
7%
Segmental Mastectomy
7%
Oncogene Proteins
7%
Mastectomy
7%
Risk Management
7%
Preliminary Data
7%
Research Ethics Committees
7%
Endometrial Neoplasms
6%
United States Food and Drug Administration
6%
Estrogen Receptors
6%
Uterine Cervical Neoplasms
6%
Weight Gain
6%
Vaccination
5%
Disease Progression
5%
Immune System
5%
Thrombosis
5%
Radiation
5%
Poisons
5%